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Summary Aim: To examine healthcare utilisation and the direct financial costs in
providing medical care to a population of children aged 5–15 years with respiratory
complaints. Secondarily, to assess whether these costs depended upon having
specific asthma diagnosis or not.
Method: A postal respiratory questionnaire was sent to the parents or guardians of
all children registered with two general practices. A search of the general practice
medical records over a 2-year reference period was made for a stratified random
sample and results are presented for 488 children aged 5–15 years.
Results: The cost of primary care lower respiratory tract consultations in children
with 4–5 symptoms/risk factors was d17.02 per patient per year for those with a
previous diagnosis of asthma compared with d6.08 per patient per year for those
with the same number of symptoms but no diagnosis (t ¼ 4:446; Po0:001). The cost
of primary care lower respiratory consultations in those with no GP diagnosis of
asthma and no symptoms/risk factors was d2.25 per patient per year.
Conclusions: Studies, which fail to include the costs associated with treating
children with respiratory symptoms but without a formal diagnosis, will seriously
underestimate the costs of treating asthmatic children.
& 2003 Elsevier Ltd. All rights reserved.
Introduction
Over the previous two decades there has been a
rising prevalence of asthma in many countries,
including the UK.1–4 Although it has been said that
this has placed an increasing burden on healthcare
services,5–7 the actual burden has been difficult to
quantify. Firstly, there is no generally accepted
method of calculating healthcare utilisation and
direct financial costs.8 In addition, healthcare
services used in different parts of the system,
(e.g. primary and secondary care sectors) have
rarely been included for one population in the same
study;9 nor have the costs associated with mana-
ging symptomatic individuals without a formal
clinical diagnosis been considered. This may be
particularly important for common conditions such
as asthma, which are said to be underdiagnosed.10
The present study examines these issues in two
general practice (GP) populations in children aged
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5–15 years. These two populations are in Wythen-
shawe, a large housing estate in South Manchester.
This estate is characterised by high levels of
deprivation with the area being in the most
deprived 10% of the country with high levels of ill
health.11
Aim
To examine healthcare utilisation and the direct
financial costs in providing medical care to a
population of children aged 5–15 years with
respiratory complaints. Secondarily, to assess
whether these costs depended upon having specific
asthma diagnosis or not.
Subjects
1. Those with likely asthma (defined as three or
more symptoms/risk factors reported from five
key questions) but with no recorded diagnosis in
the GP records of ‘‘asthma ever’’ or medication
for asthma in the previous 12 months.
2. Those with likely asthma and with a recorded
diagnosis in the GP records of ‘‘asthma ever’’ or
medication for asthma in the previous 12
months.
3. Those with less than three symptoms/risk factors
reported to the five key questions and no
recorded diagnosis in the GP records of ‘‘asthma
ever’’ or medication for asthma in the previous
12 months.
Method
In May 1993, a postal respiratory questionnaire
based on the International Study of Asthma and
Allergy in Children study12 was sent to the parents
or guardians of all children aged 15 years or less
registered with two GPs in Manchester. Reminders
were sent to non-responders after 4 and 8 weeks.
To estimate the burden of care to the medical
services, all responders were stratified into four
categories according to the number of symptoms/
risk factors (0, 1–2, 3, 4–5) reported from the
following five key questions on the questionnaire.
1. Has your child had wheezing or whistling in the
chest in the last 12 months?
2. In the last 12 months, has your child had a dry
cough at night, apart from a cough associated
with a cold or chest infection?
3. Has your child had more than three courses of
antibiotics for respiratory infections (chest, ears
or throat) in the last 12 months?
4. Has your child had hay fever or eczema?
5. Has anyone in your child’s family (parents,
grandparents, sisters or brothers) had asthma?
A random sample of 200 children from each
category was identified and a researcher and a
general practitioner searched the GP records.
Healthcare utilisation
Details of all primary care consultations (including
those occurring in the surgery and at the patients
home, during both the day and the night), all
prescriptions issued by the practice and all tests
requested were collated retrospectively for the 2-
year period following the initial questionnaire
mailing. Information regarding secondary care use
(outpatient contacts and inpatient care) was also
collected from the GP medical records. As records
of Accident and Emergency (A&E) attendances
were not routinely notified to the practices, this
information was obtained directly by search of
local A&E records.
The data collected were used to calculate the
costs detailed below. Primary care costs were
divided into consultations, GP requested investiga-
tions and prescribed medications. Consultation
costs were calculated by relating healthcare
utilisation data to total practice income. Access
to accounts for the generation of cost estimates
was only available for one GP. The income this
practice receives from the provision of general
medical services is broadly comparable to the UK
norm. The GP accounts included the costs of
running the practice, e.g. salaries of practice staff,
building, heating and lighting, etc. but excluded
the costs associated with drugs and payment of
secondary care for services. Using data for the 314
children from this practice; the mean number of
consultations (surgery, day-time home visits and
night-time home visits) in each of the four
symptoms/risk factor response categories was
calculated. This was then applied to all responders
to the questionnaire in each group (n ¼ 1069), and
an overall mean consultation rate for all responders
calculated. In the absence of evidence to the
contrary, the consultation rate in non-responders
was assumed to be the same and this was then
applied to all children on the practice list during
the reference period (n ¼ 1625) to give the
consultation rate of 5–15 year olds separated into
surgery, day-time home visits and night-time
home visits. Since practice income could not be
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apportioned between adults and children, this
process was replicated for adults and children aged
under 5 years. The average consultation time at the
time of this study was 7.5min (1 unit) and it was
estimated that a home visit during the day took
15min (2 units). A night-time home visit was
estimated to take 1 h (8 units), which included the
doctor’s travel to and from home. The practice
income was divided by the number of units
of 7.5-min GP time to give the cost per (unit)
consultation. The time taken for day and night
home visits was arrived at after discussions
with general practitioners in this practice and
are unlikely to have differed greatly between
practices.
The average cost of a surgery consultation was
determined from the total practice income for the
2-year period (p) on the assumption that all
practice activity is in some way related to the
consultation. The average cost of a surgery
consultation is represented by x, c represents the
total number of surgery consultations, h the total
number of day home visits, and n the total number
of night home visits. A day-time home visit is
estimated to cost twice that of a day surgery
consultation, and a night-time home visit eight
times the cost due to the estimated time taken to
perform the task
x ¼
p
cþ 2hþ 8n
:
The cost of GP requested investigations were
calculated by summing the charges made to the
practice for each type of test and dividing this
figure by the number of tests performed. The data
were available from fund-holding costs operating at
the time of the study.
Medication costs for each prescription written
were calculated using a computer program ob-
tained from the Prescription Pricing Authority13 an
organisation that collates all the information from
prescriptions in the UK.
Secondary care costs in 1993/94 and 1994/95
were not available. To determine the cost of
secondary care to correspond with the primary
care data collection period, cost data from the
local NHS Trust for 1998/99 were used and adjusted
for inflation since 1993 using Bank of England data.
Mean costs per day were calculated for each
speciality using the number of children admitted
within each speciality, the number of inpatient
days and the total expenditure by each speciality.
These data detailed the number of children
admitted to each specialty with the number of
days as an inpatient and the total expenditure by
each specialty. These results were then aggregated
into costs relating to lower, upper and non-
respiratory illness. Upper respiratory illness was
defined as conditions relating to the ears, nose and
throat. Lower respiratory illness was defined as
conditions relating to the lungs. All other condi-
tions were classified as non-respiratory. Similar
data were available for outpatient consultations.
Costs for A&E consultations were also established
using cost and utilisation data from the Trust. These
data were not recorded by presenting complaint;
therefore, a mean cost per A&E consultation for
any condition was derived.
The unit costs established in the study are shown
in Table 1.
A scoring system was proposed to identify
children aged 5–15 years with ‘‘likely asthma’’.
Three or more symptoms/risk factors from five on
the postal respiratory questionnaire was the
threshold for likely asthma. This scoring system
was validated in children aged 5–15 years and gave
a high positive predictive value of 84% (confidence
interval 74–90) for identifying children who would
benefit from a trial of inhaled asthma medication.14
For this paper, children with such scores were
categorised as having ‘‘likely asthma’’.
A GP diagnosis of asthma included all children
with a diagnosis of asthma ever recorded in their
GP notes and also those children who had been
issued with a prescription for an inhaled asthma
medication in the proceeding 12 months.
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Table 1 Unit costs of health care.
Primary care
Contact Surgery consultation d8.61
Day home visit d17.22
Night home visit d68.88
Tests Chest X-ray d7.50
Other X-ray d13.25
Haematology d9.41
Biochemistry d4.83
Microbiology d15.80
Secondary care
Out-patient Lower respiratory d97.94
Upper respiratory d99.91
Non-respiratory d56.32
In-patient day Lower respiratory d210.71
Upper respiratory d273.58
Non-respiratory d422.09
Accident and emergency d50.54
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Results
A total of 3653 questionnaires were sent out to
parents or guardians. After two reminders to non-
responders, 2659 replies were received, giving a
response rate of 72.8%. The population was
predominately Caucasian and of lower socio-eco-
nomic status. Responses to the questionnaire were
very similar between the two GPs; so replies from
the two populations were combined.
Of the 800 children identified for additional data
collection, 86 children were excluded because
their records were missing following data collection
and one child had died. Of the remaining 713 for
whom adequate information was available, 488
were aged 5–15 years and were included in the
present analysis (Table 2).
The cost of GP consultations increased as the
number of symptoms/risk factors reported on the
questionnaire increased (Table 3), particularly for
consultations for lower respiratory illness (from
d2.37 in those with no symptoms/risk factors to
d13.96 in those with 4–5 symptoms/risk factors).
The costs for non-respiratory consultations showed
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Table 2 Number of individuals in each questionnaire response group by age, availability of data and presence of
a GP diagnosis of asthma.
Symptoms/
risk factors
Responders with
complete questions
aged 5–15 years old
5–15 year
olds available
for analysis
Responders with complete questions (5–15 years old)
GP asthma diagnosis
Yes No Total
0 482 136 70 412 482
1–2 929 128 190 739 929
3 191 106 105 86 191
4–5 191 118 142 49 191
Total 1793 488 507 1286 1793
Table 3 Mean cost per patient per year (d) of surgery/outpatient consultations, prescriptions and secondary
care by number of symptoms/risk factors from five key questions (95% confidence interval).
Number of symptoms/risk factors
0 1–2 3 4–5
n ¼ 136 n ¼ 128 n ¼ 106 n ¼ 118
Primary care consultations
Lower respiratory 2.37 [1.43–3.31] 3.55 [2.38–4.72] 12.29 [8.66–15.92] 13.96 [10.75–17.17]
Upper respiratory 7.03 [5.13–8.94] 9.13 [7.17–11.10] 12.70 [9.38–16.02] 12.20 [9.23–15.17]
Non-respiratory 19.23 [15.84–22.63] 24.25 [19.52–28.98] 19.41 [15.84–22.98] 23.80 [19.78–27.82]
Prescriptions
Respiratory 3.24 [1.18–5.30] 4.95 [2.92–6.97] 21.49 [13.36–29.62] 36.01 [24.06–47.96]
Non-respiratory 7.90 [1.09–14.71] 5.69 [3.50–7.89] 7.95 [5.59–10.32] 11.81 [6.81–16.82]
Prescriptions total 11.14 [3.98–18.31] 10.64 [7.34–13.94] 29.44 [20.66–38.24] 47.82 [34.49–61.15]
All Primary care 28.64 [24.10–33.18] 36.93 [31.36–42.51] 44.40 [37.15–51.66] 49.96 [43.24–56.68]
Secondary care
Lower respiratory 2.09 [–1.70–5.89] 1.53 [–0.60–3.66] 3.78 [–0.10–7.66] 14.76 [4.00–25.52]
Upper respiratory 20.24 [5.47–35.03] 23.63 [7.25–40.01] 26.01 [7.62–44.41] 53.62 [28.30–78.94]
Non-respiratory 81.16 [34.00–128.31] 93.12 [53.12–133.12] 75.03 [20.93–129.14] 130.19 [45.91–214.48]
All secondary care 103.50 118.28 104.83 198.58
[54.51–152.49] [75.58–160.98] [46.98–162.69] [111.59–285.57]
All care 143.28 165.85 178.67 296.36
[87.88–198.69] [119.91–211.79] [118.56–238.81] [203.50–389.23]
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no clear trend across positive response categories.
The mean cost of primary care prescribed respira-
tory medications per patient per year was d3.24 for
those with no symptoms/risk factors compared
to d36.01 for those with 4–5 symptoms/risk
factors.
The cost of secondary care also increased as the
number of symptoms/risk factors rose (Table 3),
particularly for lower respiratory illness (from
d2.09 in those with none to d14.76 per patient
per year for those with four or five symptoms/risk
factors. The number of respiratory symptoms/risk
factors was also related to the mean annual cost of
consultations for upper respiratory conditions in
both primary and secondary care.
The mean number of inpatient days per patient
per year of in those with four or five symptoms risk
factors (0.39, 95% confidence interval 0.19–0.59)
were higher than those with fewer symptoms/risk
factors (Table 4). Similar results were seen for
inpatient stays.
When the data were stratified by whether there
was evidence of a GP diagnosis of asthma; children
with a diagnosis of asthma tended to have higher
primary and secondary care costs than those
without such a diagnosis, regardless of the number
of symptoms reported (Table 5). For example, the
cost of primary care lower respiratory tract con-
sultations in children with 4–5 symptoms/risk
factors was d17.02 per patient per year for those
with a previous diagnosis of asthma compared with
d6.08 per patient per year for those with the same
number of symptoms but no diagnosis. The cost of
primary care lower respiratory consultations in
those with no GP diagnosis of asthma and no
symptoms/risk factors was d2.25.
Those diagnosed asthmatics with three or more
symptoms/risk factors accounted for the highest
mean yearly NHS cost d260.25, compared with
diagnosed asthmatics with fewer symptoms/risk
factors costing d231.58. Children with no GP
diagnosis of asthma had a mean annual cost of
d201.26 if they had three or more symptoms /risk
factors and d152.76 if they had fewer or no
symptoms/risk factors.
When children whose parents reported three or
more symptoms/risk factors (likely asthma) were
compared with those who had fewer symptoms,
significant differences were seen in the mean
annual cost for several categories of healthcare
(Table 6). The mean cost of primary care consulta-
tions in the less symptomatic group was d2.93
compared to d13.17 in those with the greater
likelihood of respiratory disease (Po0:001). Similar
differences were found for respiratory prescrip-
tions (d4.05 and d29.14, Po0:001) and secondary
care for lower respiratory conditions (d1.81 and
d9.57, P ¼ 0:017). The overall mean costs of
primary care and of all care irrespective of sector
were also significantly higher for those in the group
with more than three symptoms/risk factors.
The proportion of healthcare events, and asso-
ciated NHS costs in primary and secondary care
consultations for lower, upper and non-respiratory
illnesses, extrapolated to the whole study popula-
tion, are shown in Fig. 1. In each illness group, most
consultations occurred in the primary care,
although large proportions of costs were incurred
in the secondary care sector.
Discussion
It is noteworthy that many of the healthcare costs
for children in this study with three or more
symptoms/risk factors (likely asthma) but without
a GP diagnosis of asthma were higher than those
without a diagnosis of asthma with fewer symp-
toms. This indicates that many children are requir-
ing and receiving care even though they have no
formal diagnosis. Studies, which fail to include the
costs associated with treating symptomatic chil-
dren without a formal diagnosis, will underestimate
the costs of treating children with the condition.
This is particularly important for conditions like
asthma where there is still a high frequency of
underdiagnosis. We have previously estimated that
around 7.9% of all children in the study population
have undiagnosed asthma.10
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Table 4 Mean number of inpatient days/stays per patient per year by number of symptoms/risk factors from five
key questions (95% confidence interval).
Number of symptoms/risk factors
0 1–2 3 4–5
n ¼ 136 n ¼ 128 n ¼ 106 n ¼ 118
Inpatient days 0.19 [0.08–0.30] 0.18 [0.08–0.28] 0.18 [0.04–0.32] 0.39 [0.19–0.59]
Inpatient stays 0.07 [0.03–0.10] 0.08 [0.04–0.11] 0.06 [0.02–0.09] 0.13 [0.08–0.17]
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Table 5 The mean cost (d) of surgery/outpatient consultations, prescriptions and secondary care (per patient per year) by GP diagnosis of asthma (95%
confidence interval).
Symptoms/risk factors
0 1–2 3 4–5
n ¼ 9 n ¼ 127 n ¼ 27 n ¼ 101 n ¼ 60 n ¼ 46 n ¼ 85 n ¼ 33
Diagnosis No diagnosis Diagnosis No diagnosis Diagnosis No diagnosis Diagnosis No diagnosis
Primary care
Lower respiratory 4.07 2.25 8.98 2.09 16.98 6.17 17.02 6.08
[1.66–6.47] [1.25–3.25] [5.22–12.73] [1.15–3.04] [11.14–22.82] [3.32–9.02] [12.83–21.22] [3.49–8.67]
Upper respiratory 10.76 6.77 8.29 9.36 13.22 12.02 12.38 11.74
[2.57–18.95] [4.79–8.75] [4.04–12.54] [7.16–11.61] [8.79–17.65] [6.82–17.23] [8.97–15.79] [5.48–18.01]
Non-respiratory 20.12 19.17 21.45 25.00 19.55 19.23 24.91 20.94
[6.58–33.67] [15.62–22.72] [13.25–29.66] [19.36–30.64] [14.96–24.14] [13.38–25.08] [20.40–29.42] [12.14–29.73]
Prescriptions
Respiratory 17.88 2.20 12.53 2.92 31.06 9.01 48.02 5.06
[14.89–50.65] [1.30–3.11] [4.94–20.11] [1.46–4.38] [18.76–43.37] [0.09–17.93] [32.11–63.94] [2.56–7.57]
Non-respiratory 56.29 4.47 9.90 4.56 9.03 6.55 14.17 5.73
[58.48–
171.06]
[2.43–6.51] [1.15–18.67] [2.96–6.17] [5.55–12.51] [3.42–9.69] [7.44–20.91] [1.50–9.97]
Prescriptions total 74.17 6.67 22.43 7.48 40.09 15.56 62.19 10.79
[40.65–
188.99]
[4.25–9.11] [10.55–34.32] [4.91–10.06] [26.83–53.35] [5.91–25.21] [44.65–79.74] [5.55–16.04]
All primary care 34.95 28.19 38.72 36.45 49.75 37.43 54.31 38.75
[20.17–49.74] [23.41–32.97] [27.08–50.37] [30.02–42.89] [39.14–60.36] [27.97–46.89] [45.93–62.69] [28.55–48.96]
Secondary care
Lower respiratory 28.85 0.20 7.25 0 4.50 2.83 16.48 10.34
[37.68–95.39] [0.19–0.59] [3.09–17.59] [0–0] [0.90–9.90] [2.88–8.56 [3.73–29.23] [10.73–31.41]
Upper respiratory 59.28 17.48 35.84 20.36 21.67 31.68 41.08 85.92
[70.30–
188.88]
[3.64–31.33] [18.50–90.18] [4.84–35.88] [1.37–44.72] [0.83–62.53] [15.53–66.64] [22.30–149.53]
Non-respiratory 259.20 68.54 44.48 106.12 44.78 114.50 159.72 54.13
[323.19–
841.60]
[31.72–105.36] [3.36–85.62] [56.65–155.60] [20.98–68.59] [8.02–237.02] [43.79–275.66] [11.03–97.24]
All secondary care 347.34 86.22 87.58 126.49 70.96 149.02 217.28 150.40
[226.81–
921.50]
[47.18–125.27] [19.87–155.29] [75.10–177.87] [0.17–111.74] [25.01–273.02] [99.23–335.34] [77.12–223.68]
All care 456.46 121.08 148.73 170.42 160.80 202.01 333.78 199.94
[227.95–
1140.88]
[79.34–162.85] [68.06–229.42] [115.75–
225.10]
[112.88–
208.72]
[75.55–328.48] [208.25–
459.34]
[123.90–
275.99]
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Children who do not have formal diagnoses can
be included in cost analyses based on responses to a
questionnaire. Alternatively, records of presenting
symptoms can be used in addition to recorded
diagnoses. The widespread use of computerised GP
records makes this more practical than in solely
paper-based settings.
Previous work has shown that primary and
secondary healthcare utilisation increases as the
number of symptoms/risk factors to key questions
on a respiratory questionnaire rises.15 This paper
now quantifies the healthcare costs associated with
these increases. As found by other studies, most
care took place in the primary sector whereas most
cost was associated with secondary care usage.16–18
Other studies have also found that children with
asthma utilise a greater proportion of services than
those without the diagnosis, whether for respira-
tory or non-respiratory illness.5–7
The relationship between respiratory symptoms/
risk factors and mean annual cost of consultations
was evident for both lower and upper respiratory
conditions, which provides further evidence that
the airways need to be considered as a whole-
Fconditions of the lung can impact on the ears,
nose and throat and vice versa.
Earlier studies have established costs for a GP
consultation using different methods, usually based
on estimates. One study in 1997 estimated the cost
of a GP consultation to be d9.00 and a nurse
consultation d6.00.19,20 Another derived a cost of
d6.90 (7d2.73) in 1995/96 for a GP consultation.9
The cost of a primary care consultation obtained in
the present study from actual practice data was
d8.61, similar to those found by others.
This study did not differentiate between con-
sultations occurring with a GP or a practice nurse. It
was decided that the longer appointment times
assigned for a nurse consultation would balance the
difference in remuneration between GPs and
practice nurses. A study in Sheffield examined the
costs of consultations in GP and estimated that a
day-time GP contact cost d7.32 with a home visit
costing d14.75 and a day-time nurse consultation
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Table 6 The mean cost (d) of surgery/outpatient consultations, GP tests and prescriptions (per patient per year)
by presence of three or more symptoms/risk factors from five key questions.
Number of symptoms/risk factors
Less than three Three or more t P
n ¼ 265 n ¼ 224
Primary care consultations
Lower respiratory 2.93 13.17 8.05 o0.001
Upper respiratory 8.02 12.44 3.36 0.001
Non-respiratory 21.60 21.72 0.06 0.952
Prescriptions
Respiratory 4.05 29.14 6.57 o0.001
Non-respiratory 6.82 9.99 1.35 0.178
Prescriptions total 10.88 31.13 6.11 o0.001
All Primary care 32.55 47.33 4.79 o0.001
Secondary care
Lower respiratory 1.81 9.57 2.41 0.017
Upper respiratory 21.81 40.56 1.92 0.056
Non-respiratory 86.63 104.09 0.58 0.564
All secondary care 110.25 154.22 1.39 0.166
All care 153.68 240.68 2.55 0.011
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Figure 1 Illness categoriesFtotal number and cost of
consultations over the 2-year period (n ¼ 488).
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costing d6.89.21 These figures compare favourably
with our assumptions of a nurse consultation
costing the same as a GP consultation and a day-
time home visit costing twice as much, reflecting
the time taken by the health professional to
perform the task and so are comparable to our
calculations.
The prescribing costs of respiratory and non-
respiratory medication rose with the number of
symptoms/risk factors reported, both in those
children with a GP diagnosis of asthma and those
with no diagnosis. It is possible that antibiotics for
respiratory conditions, hay fever and eczema
medications drove these patterns of expenditure.
It has previously been shown that patients receive
several courses of antibiotics before being diag-
nosed as being asthmatic.22
Earlier work examined possible response bias to
the postal questionnaire in this population; no
important differences were found.23
The stratified sample was designed to ‘‘enrich’’
the sample in favour of those likely to have asthma
compared to the distribution in the general
population. Due to available resources, only a
finite number of GP records could be examined.
Thus it was considered important to select equal
numbers of subjects for record examination in each
of the symptom/risk factor groups. The selected
group also included children aged less than 5 years,
whose results are not presented here, owing to
differences in the likely aetiology of symptoms.
This study has some important limitations. The
medication data were obtained from records of
prescriptions issued, not actually medication dis-
pensed. A previous study has found that up to 20%
of patients do not submit their prescription for
dispensing,24 and thus the costs presented may be
overestimates. The costs will also have been
inflated by an unknown amount because of the
treatment of children with mild, self-limiting
symptoms, or because of an incorrect diagnosis of
asthma.
The source of data was GP records and under
recording of hospital utilisation may have occurred.
If this occurred randomly it would tend to under-
estimate our costs; however, if one speciality was
more likely to send clinic letters and discharge
summaries to the GP, bias could have been
introduced. While it is possible that the dissemina-
tion of a respiratory questionnaire may have
increased awareness and thus affected patient
and GP behaviours, it is difficult to quantify any
possible effect. It is also likely that any effect
would have been short term, and thus minimised by
the collection of utilisation data over 2 whole
years. Data had to be collected retrospectively at
the end of the 2-year period, due to logistical and
practical limitations of the study. Neither patients
nor GPs were informed of the results of the
categorisation during the period of data collection.
It is possible that some of the children who did not
have an asthma diagnosis in 1993 would have
subsequently been diagnosed by 1995.This informa-
tion was not collected and may have had some
impact on our results. Although the derivation of
the cost of a consultation was based on the
accounts of one GP, utilisation data were collected
from two GPs. Although no formal evaluation of
wider applicability was made, the results include
consultations with nine partners; four trainees and
five practice nurses and thus reflect the practice
behaviours of a number of healthcare professionals.
The methods used to collect the data and the
data collected have not been validated. This could
be done by repeating the study in a number of
settings on a number of occasions but is limited by
time and cost constraints. While there is no single
widely accepted method for obtaining the costs of
a consultation validation against a gold standard is
not possible. Comparison with the results of other
similar studies provides evidence for the validity of
the methods used here.
The population studied had a consultation rate of
3.5 per person per year compared with 2.5 per
person per year seen in the 2001 UK national
census.25 This higher consultation rate could be
explained by the practices being in a deprived area
with known high levels of ill health. The secondary
care cost data did not specifically relate to the
randomly sampled patients involved in the study, as
this type of information was not available. How-
ever, data were obtained from the local NHS Trust
where most patients from the practices receive
their care. For those that received secondary care
elsewhere, it was assumed that the costs of
treatment would be similar. The cost data pre-
sented here relate to the period 1993–1995. It must
therefore be acknowledged that circumstances and
care may have changed since then. Due to inflation,
the costs presented here will be lower than the
equivalent present-day values. However, there is
little evidence for substantial change, either in
diagnosis (e.g. there is still no gold standard for
asthma diagnosis) or in the system of healthcare
delivery.
There were only eight children who had a
consultation in A&E for a respiratory problem
possibly indicating inaccurate recording of consul-
tations by A&E. However, 32.5% (n ¼ 232) of the
total sample attended A&E during the study period
for a non-respiratory problem, which suggests A&E
attendances were being picked up successfully by
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the study team. The low figure for respiratory
related attendances in both A&E and secondary
care (37 children) suggests that most children in
the study population were receiving treatment for
their respiratory illness in primary care.
The mean number of inpatient stays per patient
per year varies between 0.07 and 0.13 (Table 4)
depending on the number of symptoms risk factors.
This is comparable with a figure of 0.06 found in the
UK General Household Survey.25
Weiss et al.26 state that financial resources need
to be directed towards asthma in a more effective
way and that ‘‘overall costs are not as important as
their relative distribution’’, across patients and
types of healthcare. With the introduction of
Primary Care Trusts in the UK, practitioners will
have increasing amounts of responsibility for the
purchasing of services. In order to do this efficiently
and equitably; the costs of services need to be
known. A fundamental part of any priority setting
programme is the availability of relevant and
comprehensive costs; data that this study provides.
In essence, clinicians and managers must both
contribute to decisions on resource allocation in
order to optimise outcomes in asthma care and in
care for other illnesses.18 Failure to consider the
costs associated with treating symptomatic chil-
dren without a clinical diagnosis of asthma will
underestimate the resources needed to manage
such children, both for their respiratory and non-
respiratory problems.
Conclusion
Despite the absence of a formal diagnosis, children
with respiratory symptoms are important users of
healthcare services. The importance of including
such children in studies of cost is considerable if
underestimation of the costs of treating children
with asthma is to be avoided.
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